ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
NZ Trader
|
239 |
61K |
37 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
239
|
61K
|
37
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
NZ Trader
|
8.3K |
3.0M |
39 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
8.3K
|
3.0M
|
39
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
NZ Trader
|
8.3K |
3.0M |
7 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
8.3K
|
3.0M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
NZ Trader
|
8.3K |
3.0M |
13 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
8.3K
|
3.0M
|
13
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
NZ Trader
|
8.3K |
3.0M |
30 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
8.3K
|
3.0M
|
30
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
NZ Trader
|
1.4K |
349K |
25 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
1.4K
|
349K
|
25
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
NZ Trader
|
1.4K |
349K |
28 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
1.4K
|
349K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
NZ Trader
|
239 |
61K |
26 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
239
|
61K
|
26
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
NZ Trader
|
239 |
61K |
32 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
239
|
61K
|
32
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
NZ Trader
|
239 |
61K |
75 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
239
|
61K
|
75
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
NZ Trader
|
12K |
4.3M |
10 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
12K
|
4.3M
|
10
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
NZ Trader
|
12K |
4.3M |
18 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
12K
|
4.3M
|
18
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric to present at NWR Virtual Healthcare Conference
|
|
NZ Trader
|
22 |
7.3K |
14 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
22
|
7.3K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
NZ Trader
|
216 |
42K |
3 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
216
|
42K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
NZ Trader
|
113 |
26K |
2 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
113
|
26K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
NZ Trader
|
216 |
42K |
13 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
216
|
42K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
NZ Trader
|
216 |
42K |
18 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
216
|
42K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
NZ Trader
|
216 |
42K |
5 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
216
|
42K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
NZ Trader
|
216 |
42K |
6 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
216
|
42K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
NZ Trader
|
216 |
42K |
3 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
216
|
42K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
NZ Trader
|
216 |
42K |
13 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
216
|
42K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
NZ Trader
|
126 |
32K |
15 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
126
|
32K
|
15
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
NZ Trader
|
113 |
26K |
3 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
113
|
26K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Clinical milestones for 2024 & 2023 successes highlighted
|
|
NZ Trader
|
26 |
9.3K |
10 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
26
|
9.3K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
NZ Trader
|
216 |
42K |
14 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
216
|
42K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
NZ Trader
|
317 |
80K |
14 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
317
|
80K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
NZ Trader
|
216 |
42K |
24 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
216
|
42K
|
24
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
NZ Trader
|
216 |
42K |
12 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
216
|
42K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
NZ Trader
|
1.4K |
349K |
12 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
1.4K
|
349K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Any help appreciated
|
|
NZ Trader
|
5 |
1.4K |
10 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
5
|
1.4K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
share dumping
|
|
NZ Trader
|
17 |
4.1K |
11 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
17
|
4.1K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
NZ Trader
|
216 |
42K |
13 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
216
|
42K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
NZ Trader
|
317 |
80K |
11 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
317
|
80K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
NZ Trader
|
216 |
42K |
18 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
216
|
42K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
NZ Trader
|
317 |
80K |
10 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
317
|
80K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
NZ Trader
|
317 |
80K |
13 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
317
|
80K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
NZ Trader
|
317 |
80K |
6 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
317
|
80K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
NZ Trader
|
153 |
42K |
4 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
153
|
42K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
NZ Trader
|
1.4K |
349K |
25 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
1.4K
|
349K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Singapore Healthcare Day Presentation
|
|
NZ Trader
|
63 |
17K |
33 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
63
|
17K
|
33
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
NZ Trader
|
100 |
27K |
22 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
100
|
27K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Singapore Healthcare Day Presentation
|
|
NZ Trader
|
63 |
17K |
8 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
63
|
17K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Singapore Healthcare Day Presentation
|
|
NZ Trader
|
63 |
17K |
23 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
63
|
17K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
NZ Trader
|
282 |
74K |
5 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
282
|
74K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
NZ Trader
|
1.4K |
349K |
22 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
1.4K
|
349K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
NZ Trader
|
100 |
27K |
8 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
100
|
27K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
NZ Trader
|
100 |
27K |
30 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
100
|
27K
|
30
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Singapore Healthcare Day Presentation
|
|
NZ Trader
|
63 |
17K |
28 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
63
|
17K
|
28
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
NZ Trader
|
1.4K |
349K |
19 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
1.4K
|
349K
|
19
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
NZ Trader
|
1.4K |
349K |
16 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
1.4K
|
349K
|
16
|
|